29 June 2026
: Case report
[In Press] Anterior ST-Segment Elevation Myocardial Infarction Shortly After Cefaclor Exposure: A Case Report Highlighting Kounis Syndrome as a Differential Diagnosis
Unusual clinical course, Challenging differential diagnosis, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Quan Zuo1ABCDEFG, Yue Zhu1BE, Zhiwei Wang1BE, Tao Ge1ABCDEFGDOI: 10.12659/AJCR.953705
Am J Case Rep In Press; DOI: 10.12659/AJCR.953705
Available online: 2026-06-29, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Kounis syndrome is an acute coronary syndrome associated with allergic or hypersensitivity reactions, but establishment of causality is difficult when objective allergy-related tests are unavailable during emergency treatment. This report describes anterior ST-segment elevation myocardial infarction (STEMI) occurring shortly after cefaclor exposure and highlights the diagnostic limitations of attributing the event to hypersensitivity in routine emergency clinical practice.
CASE REPORT
A 61-year-old man with a history of positive penicillin skin testing, but no prior penicillin administration, developed severe chest pain approximately 1 hour after self-administration of oral cefaclor for respiratory symptoms. He had no rash, urticaria, wheezing, angioedema, oropharyngeal edema, hypotension, or dyspnea; no prehospital antihistamines, corticosteroids, or epinephrine were administered. Electrocardiography showed ST-segment elevation in V2 to V6, and emergency coronary angiography demonstrated 90% proximal left anterior descending artery stenosis with Thrombolysis in Myocardial Infarction grade II flow. Primary percutaneous coronary intervention restored grade III flow and relieved symptoms. High-sensitivity cardiac troponin I increased from 0.57 to 1.10 ng/mL and peaked at 3.92 ng/mL at 15 hours. Serum tryptase, histamine, total and specific IgE, and intracoronary imaging were not obtained. The Naranjo score was 2, indicating a possible adverse drug reaction.
CONCLUSIONS
The temporal association prompted consideration of Kounis syndrome, but severe fixed coronary stenosis makes coincidental plaque-related STEMI a major alternative diagnosis. Early allergy biomarker sampling and careful causal assessment are important in similar cases.
Keywords: Cephalosporins; Myocardial Infarction; Drug Hypersensitivity; Percutaneous Coronary Intervention; Case Reports
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.951271
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953050
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952134
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953705
Most Viewed Current Articles
07 Dec 2021 : Case report
22,102,454
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
173,700
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
119,450
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
64,406
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






